Some psychedelic drugs, once considered fringe, are now getting a step closer to possibly being approved for use as mental ...
The FDA's Fast Track designation helps to accelerate the development and review of products for serious and life-threatening conditions. The Food and Drug Administration (FDA) has granted Fast Track ...
France will introduce in 2026 a “fast-track” pathway aimed at accelerating the authorisation of certain mono-national clinical trials. Reserved in particular for early-phase studies, serious diseases ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results